A biodegradable PEG-based micro-cavitary hydrogel as scaffold for cartilage tissue engineering

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

39 Scopus Citations
View graph of relations

Author(s)

Detail(s)

Original languageEnglish
Pages (from-to)651-660
Journal / PublicationEuropean Polymer Journal
Volume72
Publication statusPublished - 26 Feb 2015
Externally publishedYes

Abstract

We developed a micro-cavitary hydrogel (MCG) via photo-polymerization of biodegradable oligo(trimethylene carbonate)-poly(ethylene glycol)-oligo(trimethylene carbonate) diacrylate (TPT-DA) macromer, in which cavities with hundreds of microns in diameter were created using gelatin micro-spherical porogens. The capacity of this TPT-DA based MCG (TPT-MCG) as scaffolds for cartilage tissue engineering was deployed and measured by comparing it with conventional, non-cavitary TPT-DA based hydrogels (TPT-G). Besides the influence on physical properties (e.g. swelling behavior, crosslink density, etc.), the micro-cavitary structure properly accelerated degradation of TPT-MCG constructs, which benefited cell proliferation and production of cartilage-specific extracellular matrix (ECM). After 21 days of culture, the cell density in TPT-MCG constructs was 5.6-folds higher than that in TPT-G constructs. The total contents of collagen and glycosaminoglycan (GAG) in TPT-MCG constructs was up to 833 mg per gram dry weight in contrast with 273 mg per gram dry weight in TPT-G counterparts. Furthermore, the ECM networks were clearly observed in TPT-MCG constructs. These results indicate the superiority of TPT-MCG as scaffold for cartilage regeneration.

Research Area(s)

  • Cartilage, Degradation, Hydrogel, Poly(ethylene glycol), Tissue engineering, Trimethylene carbonate

Bibliographic Note

Publication details (e.g. title, author(s), publication statuses and dates) are captured on an “AS IS” and “AS AVAILABLE” basis at the time of record harvesting from the data source. Suggestions for further amendments or supplementary information can be sent to [email protected].